Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 19;9:975. doi: 10.3389/fphar.2018.00975

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Rodrigues, de Oliveira Freire, Carvalho, Silva, Vasconcelos, Guerra, de Sousa Cartágenes and Garcia.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Histopathologic assessment of cartilage classified using the Osteoarthritis Research Society International (OARSI) scoring system. Groups: PROF250, prophylactically administered SrRan 250 mg/kg 4 weeks before OA induction; SR250 and SR500, OA-induced and treated with SrRan 250 and 500 mg/kg, respectively for 4 weeks after induction; SAL, OA-induced and receiving only saline; CONTROL, untreated and not OA-induced. Results are means ± SD; ^∗p < 0.05, comparing PROF250, SR250, and SR500 and SAL groups, using one-way analysis of variance (ANOVA), followed by Bonferroni test. Y-axis: Histological assessment of cartilage (OARSI Classification).